サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/17 | 1,300 | 1,314 | 1,241 | 1,250 | -50 | -3.8% | 390,000 |
2022/01/14 | 1,250 | 1,321 | 1,242 | 1,300 | +50 | +4% | 671,900 |
2022/01/13 | 1,250 | 1,273 | 1,239 | 1,250 | -43 | -3.3% | 380,800 |
2022/01/12 | 1,303 | 1,325 | 1,255 | 1,293 | -11 | -0.8% | 855,200 |
2022/01/11 | 1,171 | 1,325 | 1,160 | 1,304 | +125 | +10.6% | 1,564,800 |
2022/01/07 | 1,082 | 1,223 | 1,057 | 1,179 | +119 | +11.2% | 1,072,700 |
2022/01/06 | 1,055 | 1,088 | 1,053 | 1,060 | -16 | -1.5% | 294,400 |
2022/01/05 | 1,050 | 1,098 | 1,028 | 1,076 | +22 | +2.1% | 365,900 |
2022/01/04 | 1,029 | 1,059 | 1,005 | 1,054 | +47 | +4.7% | 544,500 |
2021/12/30 | 1,016 | 1,017 | 996 | 1,007 | -9 | -0.9% | 320,800 |
2021/12/29 | 1,019 | 1,038 | 990 | 1,016 | +13 | +1.3% | 472,600 |
2021/12/28 | 1,050 | 1,061 | 998 | 1,003 | -39 | -3.7% | 786,800 |
2021/12/27 | 1,108 | 1,108 | 1,037 | 1,042 | -83 | -7.4% | 711,500 |
2021/12/24 | 1,131 | 1,153 | 1,120 | 1,125 | -8 | -0.7% | 362,700 |
2021/12/23 | 1,165 | 1,172 | 1,131 | 1,133 | -40 | -3.4% | 385,700 |
2021/12/22 | 1,140 | 1,183 | 1,131 | 1,173 | +15 | +1.3% | 583,100 |
2021/12/21 | 1,214 | 1,223 | 1,138 | 1,158 | -45 | -3.7% | 844,500 |
2021/12/20 | 1,115 | 1,221 | 1,111 | 1,203 | +71 | +6.3% | 1,846,000 |
2021/12/17 | 1,177 | 1,254 | 1,044 | 1,132 | +35 | +3.2% | 6,320,300 |
2021/12/16 | 1,097 | 1,097 | 1,097 | 1,097 | +150 | +15.8% | 92,100 |
2021/12/15 | 940 | 951 | 933 | 947 | -8 | -0.8% | 442,800 |
2021/12/14 | 964 | 978 | 942 | 955 | -21 | -2.2% | 491,400 |
2021/12/13 | 1,020 | 1,030 | 968 | 976 | -49 | -4.8% | 600,700 |
2021/12/10 | 1,050 | 1,054 | 1,025 | 1,025 | -29 | -2.8% | 255,100 |
2021/12/09 | 1,049 | 1,075 | 1,041 | 1,054 | +8 | +0.8% | 365,300 |
2021/12/08 | 1,000 | 1,049 | 999 | 1,046 | +60 | +6.1% | 650,300 |
2021/12/07 | 950 | 991 | 950 | 986 | +35 | +3.7% | 604,600 |
2021/12/06 | 990 | 992 | 940 | 951 | -64 | -6.3% | 807,600 |
2021/12/03 | 987 | 1,015 | 982 | 1,015 | +34 | +3.5% | 418,100 |
2021/12/02 | 1,006 | 1,017 | 980 | 981 | -37 | -3.6% | 508,900 |
2021/12/01 | 1,033 | 1,035 | 997 | 1,018 | -15 | -1.5% | 515,400 |
2021/11/30 | 1,029 | 1,066 | 1,016 | 1,033 | +20 | +2% | 508,500 |
2021/11/29 | 1,051 | 1,073 | 1,011 | 1,013 | -70 | -6.5% | 982,500 |
2021/11/26 | 1,140 | 1,144 | 1,071 | 1,083 | -71 | -6.2% | 759,100 |
2021/11/25 | 1,164 | 1,180 | 1,137 | 1,154 | -4 | -0.3% | 361,900 |
2021/11/24 | 1,208 | 1,208 | 1,157 | 1,158 | -63 | -5.2% | 497,600 |
2021/11/22 | 1,212 | 1,227 | 1,189 | 1,221 | -10 | -0.8% | 280,800 |
2021/11/19 | 1,302 | 1,302 | 1,231 | 1,231 | -73 | -5.6% | 382,500 |
2021/11/18 | 1,291 | 1,318 | 1,261 | 1,304 | +24 | +1.9% | 644,200 |
2021/11/17 | 1,307 | 1,338 | 1,238 | 1,280 | +59 | +4.8% | 1,409,500 |
2021/11/16 | 1,203 | 1,221 | 1,182 | 1,221 | +23 | +1.9% | 227,200 |
2021/11/15 | 1,177 | 1,203 | 1,165 | 1,198 | +13 | +1.1% | 257,000 |
2021/11/12 | 1,142 | 1,191 | 1,141 | 1,185 | +29 | +2.5% | 244,500 |
2021/11/11 | 1,174 | 1,179 | 1,152 | 1,156 | -33 | -2.8% | 230,100 |
2021/11/10 | 1,177 | 1,205 | 1,168 | 1,189 | +15 | +1.3% | 208,000 |
2021/11/09 | 1,179 | 1,191 | 1,166 | 1,174 | -7 | -0.6% | 150,400 |
2021/11/08 | 1,224 | 1,224 | 1,175 | 1,181 | -44 | -3.6% | 257,900 |
2021/11/05 | 1,205 | 1,228 | 1,196 | 1,225 | +27 | +2.3% | 202,000 |
2021/11/04 | 1,245 | 1,246 | 1,193 | 1,198 | -29 | -2.4% | 260,600 |
2021/11/02 | 1,222 | 1,244 | 1,221 | 1,227 | +29 | +2.4% | 207,100 |
701~
750
件表示中 / 2354件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
あすかHD | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
タウンズ | 56,300円 | +4.6% | +6.1% | 4.97% | 9.46倍 | 4.17倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症得意 |
市場注目の銘柄
チャート関連のコラム